Precision Oncology News

Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

May 27, 2020

NEW YORK – Illumina and Genomic Medicine Sweden (GMS) on Thursday announced a collaboration to assess whether whole-genome sequencing (WGS) and RNA sequencing can replace conventional first-line clinical diagnostic methods for acute leukemia.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Menu

Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

To read the full story....

Breaking News

Tango Therapeutics to Go Public on Nasdaq Through SPAC

AstraZeneca's Tagrisso Approved in China for Adjuvant Treatment of EGFR-Mutated NSCLC

Theseus Pharmaceuticals Emerges from Stealth Mode, Raises $100M in Series B Funding

BridgeBio Rolls Out New Academic Pacts to Advance Precision Oncology Programs

AACR Study of Eli Lilly's Retevmo Shows Anti-Tumor Activity Across Cancers

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

Featured White Papers

Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

CaTCH it if you can! CRISPRa-based Exploration of Therapy Resistant Cell Clones

Disparities in Precision Oncology: Identifying Barriers and Moving Toward Solutions

What's Popular?

With Support From Lawmakers, WGS Becoming More Accessible to Netherlands' Cancer Patients

Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers

Sponsorships